Long-term Effects of COVID-19

Mayo Clinic Health System-wide Neurological, Vascular and Neurovascular Events With SARS-CoV-2- Part II

The purpose of this study is to measure, monitor, and analyze long term effects of SARS-CoV-2. The main purpose is to assess the post-hospitalization outcomes of patients who were diagnosed with SAR-CoV-2 by comparing to patients who were hospitalized with an acute neurological disease.

Inclusion Criteria:

• Control Participants: Males and females over the age of 18 years hospitalized and receiving intensive care for diagnosis's other than COVID-19 or an acute neurological disease and who were not diagnosed (clinically or with PCR testing) with COVID-19.
• Case Participants: Males and females over the age of 18 years who had been hospitalized at Mayo Clinic Hospital for treatment of COVID-19 confirmed by PCR test.
• We acknowledge that some participants may be unable to consent due to underlying medical conditions; an eligible proxy may provide the informed consent and provide a signature on the designated line.
• Women of childbearing age, between the ages of 18 to 55, must complete a negative pregnancy test.
• Minority individuals over the age of 18 years will be eligible to enroll.

Exclusion Criteria:

• Males and females, under the age of 18 years.
• Participants with PET/MRI non-compatible devices.
• Claustrophobia.
• Allergies to study related procedures.
• Pregnant , incarcerated, or institutionalized subjects will not be included in the study.